Coverage
-
August 07, 2014
A California federal judge on Thursday kept Ariosa Diagnostics Inc.'s counterclaims against DNA analysis company Illumina Inc. intact as Ariosa fights back against accusations that its prenatal Down syndrome test infringes an Illumina patent, ruling that a contract does not force Ariosa into arbitration.
1 other articles on this case.
View all »